Prochant Healthcare secures strategic investment from Longshore Capital Partners; teams from ALMT Legal, SAM, Greenberg Traurig, McDermott advise on global and India legs.

PE / VC 23 Jul 2026 · Completed· ✓ Verified

Prochant is a technology-enabled revenue cycle management services provider serving home medical equipment (HME), durable medical equipment (DME), infusion, and specialty pharmacy providers. Founded in 1999, the company operates with over 3,000 global employees and has been named to the Inc. 5000 list for six consecutive years. The investment will fund Prochant's advancement in AI, automation, technology and analytics capabilities, expansion of service capacity, and growth in core markets. Financial terms were not disclosed. The transaction appears to be a growth equity investment (not a full acquisition), with Prochant's management team retaining operational control.

Why it mattersMulti-jurisdictional PE investment in a US-domiciled healthcare tech-enabled services business requires coordinated India-leg compliance (foreign investment policy, potential GST, labour, regulatory approvals) in tandem with US capital structure; use of separate India counsel signifies distinct regulatory requirements and entity structuring considerations for offshore PE funds.
CounselALMT Legal, Shardul Amarchand Mangaldas & Co, Greenberg Traurig, McDermott Will & Emery (also referred to as 'McDermott Will & Schulte')
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals